We are live on
!
Find out more
Alnylam Pharmaceuticals
ALNY
ALNY
403 hedge funds and large institutions have $21B invested in Alnylam Pharmaceuticals in 2021 Q3 according to their latest regulatory filings, with 48 funds opening new positions, 154 increasing their positions, 122 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
98% more call options, than puts
Call options by funds: $275M | Put options by funds: $138M
26% more repeat investments, than reductions
Existing positions increased: 154 | Existing positions reduced: 122
17% more first-time investments, than exits
New positions opened: 48 | Existing positions closed: 41
10% more capital invested
Capital invested by funds: $19B → $21B (+$1.99B)
1% more funds holding
Funds holding: 400 → 403 (+3)
0% more funds holding in top 10
Funds holding in top 10: 9 → 9 (0)
1.59% less ownership
Funds ownership: 95.54% → 93.95% (-1.6%)
Holders
403
Holders Change
+3
Holders Change %
+0.75%
% of All Funds
7.06%
Holding in Top 10
9
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.16%
New
48
Increased
154
Reduced
122
Closed
41
Calls
$275M
Puts
$138M
Net Calls
+$136M
Net Calls Change
+$120M
Top Buyers
| 1 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$65.6M |
| 2 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
+$52.5M |
| 3 |
APM
Avidity Partners Management
Dallas,
Texas
|
+$43.5M |
| 4 |
BlackRock
New York
|
+$42.1M |
| 5 |
PCH
Polar Capital Holdings
London,
United Kingdom
|
+$36.7M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$339M |
| 2 |
MC
Maverick Capital
Dallas,
Texas
|
-$54.2M |
| 3 |
Alkeon Capital Management
New York
|
-$50.3M |
| 4 |
ACA
Avoro Capital Advisors
New York
|
-$28.1M |
| 5 |
JP Morgan Chase
New York
|
-$26.8M |
